Jim C. Hu, MD, MPH, will join the UCLA urology faculty in April 2012.
Jim C. Hu, MD, MPH, will join the UCLA urology faculty in April 2012.
Dr. Hu has been appointed as professor and Henry E. Singleton Chair in Urology, director of minimally invasive urology, co-director of the UCLA Center for Advanced Surgical and Interventional Technology, and director of the Urology Procedures Unit.
Dr. Hu earned his Bachelor of Science in economics and his Master of Public Health from Johns Hopkins University, Baltimore, and his medical doctorate from Baylor College of Medicine, Houston. He completed his surgery and urology residency training at UCLA and a fellowship in minimally invasive and robotic urology at City of Hope National Medical Center, Duarte, CA.
He is currently associate professor of surgery/urology at Harvard Medical School, Boston, where he serves as director of urologic robotic and minimally invasive surgery and director of the minimally invasive urologic oncology fellowship at the Brigham and Women’s Hospital, Boston.
UCLA Urology Chair Mark S. Litwin, MD, said that in addition to developing and enhancing UCLA’s clinical program in minimally invasive and robotic urologic oncology, Dr. Hu will support the department’s efforts in minimally invasive and robotic intervention in benign urology. He will also be responsible for formalizing and leading the department’s graduate medical education and continuing medical education programs in minimally invasive urology.
Go back to this issue of Urology Times eNews.
Related Content
Dr. Guru joins Roswell Park as professor of urologic oncology
Dr. Canfield named urology chief at UTHealth
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.